Ameriprise Financial Inc Neogenomics Inc Transaction History

Ameriprise Financial Inc

  • $356 Billion
  • Q1 2025

A detailed history of Ameriprise Financial Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 471,776 shares of NEO stock, worth $3.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
471,776
Previous 471,005 0.16%
Holding current value
$3.41 Million
Previous $7.76 Million 42.32%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
BUY
$9.09 - $18.61 $7,008 - $14,348
771 Added 0.16%
471,776 $4.48 Million
Q4 2024

Feb 14, 2025
SELL
$13.0 - $18.43 $158,990 - $225,398
-12,230 Reduced 2.53%
471,005 $7.76 Million
Q3 2024

Nov 14, 2024
SELL
$13.4 - $17.73 $76,272 - $100,919
-5,692 Reduced 1.16%
483,235 $7.13 Million
Q2 2024

Aug 14, 2024
SELL
$13.01 - $15.77 $672,018 - $814,583
-51,654 Reduced 9.56%
488,927 $6.78 Million
Q1 2024

May 15, 2024
SELL
$14.06 - $16.79 $247,976 - $296,125
-17,637 Reduced 3.16%
540,581 $8.5 Million
Q4 2023

Feb 14, 2024
SELL
$11.67 - $20.73 $2.55 Million - $4.52 Million
-218,259 Reduced 28.11%
558,218 $9.03 Million
Q3 2023

Nov 14, 2023
SELL
$12.15 - $17.85 $576,687 - $847,232
-47,464 Reduced 5.76%
776,477 $9.55 Million
Q2 2023

Aug 14, 2023
SELL
$14.1 - $19.83 $2.08 Million - $2.92 Million
-147,423 Reduced 15.18%
823,941 $13.2 Million
Q1 2023

May 15, 2023
SELL
$9.09 - $19.45 $2.41 Million - $5.16 Million
-265,518 Reduced 21.47%
971,364 $16.9 Million
Q4 2022

Feb 14, 2023
SELL
$6.45 - $12.07 $69,872 - $130,754
-10,833 Reduced 0.87%
1,236,882 $11.4 Million
Q3 2022

Nov 14, 2022
BUY
$7.86 - $12.91 $4.64 Million - $7.61 Million
589,695 Added 89.62%
1,247,715 $10.7 Million
Q2 2022

Aug 15, 2022
SELL
$7.06 - $13.97 $6.47 Million - $12.8 Million
-915,976 Reduced 58.19%
658,020 $5.36 Million
Q1 2022

May 16, 2022
SELL
$12.15 - $35.28 $9.15 Million - $26.6 Million
-753,266 Reduced 32.37%
1,573,996 $19.1 Million
Q4 2021

Feb 14, 2022
SELL
$30.49 - $48.49 $1.53 Million - $2.43 Million
-50,150 Reduced 2.11%
2,327,262 $79.4 Million
Q3 2021

Nov 15, 2021
SELL
$41.66 - $52.52 $4.37 Million - $5.51 Million
-104,892 Reduced 4.23%
2,377,412 $115 Million
Q2 2021

Aug 16, 2021
BUY
$36.62 - $51.69 $23.5 Million - $33.2 Million
641,439 Added 34.84%
2,482,304 $112 Million
Q1 2021

May 17, 2021
BUY
$41.56 - $59.88 $4.3 Million - $6.19 Million
103,456 Added 5.95%
1,840,865 $88.8 Million
Q4 2020

Feb 12, 2021
BUY
$36.08 - $56.47 $3.49 Million - $5.46 Million
96,756 Added 5.9%
1,737,409 $93.5 Million
Q3 2020

Nov 16, 2020
BUY
$33.26 - $40.48 $3.28 Million - $4 Million
98,691 Added 6.4%
1,640,653 $60.5 Million
Q2 2020

Aug 14, 2020
BUY
$24.21 - $31.02 $20.2 Million - $25.8 Million
832,534 Added 117.35%
1,541,962 $47.8 Million
Q1 2020

May 15, 2020
BUY
$20.5 - $34.53 $569,797 - $959,761
27,795 Added 4.08%
709,428 $19.5 Million
Q4 2019

Feb 14, 2020
BUY
$18.96 - $29.84 $39,588 - $62,305
2,088 Added 0.31%
681,633 $19.9 Million
Q3 2019

Nov 14, 2019
BUY
$19.12 - $26.24 $1.44 Million - $1.97 Million
75,205 Added 12.44%
679,545 $13 Million
Q2 2019

Aug 14, 2019
BUY
$19.57 - $24.1 $1.65 Million - $2.03 Million
84,365 Added 16.22%
604,340 $13.3 Million
Q1 2019

May 15, 2019
BUY
$12.14 - $20.46 $5.35 Million - $9.02 Million
441,024 Added 558.6%
519,975 $10.6 Million
Q4 2018

Feb 14, 2019
BUY
$11.24 - $18.5 $887,409 - $1.46 Million
78,951 New
78,951 $996,000
Q3 2018

Nov 14, 2018
SELL
$12.5 - $15.38 $813,500 - $1 Million
-65,080 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$7.99 - $14.05 $519,989 - $914,374
65,080 New
65,080 $853,000

Others Institutions Holding NEO

# of Institutions
288
Shares Held
127M
Call Options Held
942K
Put Options Held
172K
View Full List

About NEOGENOMICS INC

NEO Quotes by TradingView
  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $910M
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email